Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1288 of 5804
-
AI eye on cancer: robot helps spot hidden polyps
Diagnosis Recruiting nowThe study aims to evaluate the effectiveness of artificial intelligence-assisted colonoscopy in increasing adenoma detection rate and the accuracy in the characterization of colorectal lesions, compared to standard colonoscopy, in a randomized controlled clinical trial setting.
Phase: NA • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Could a steroid shot help tiny preemies survive shock?
Disease control OngoingThe goal of this clinical trial is to determine the effectiveness of early use of hydrocortisone (since the diagnosis of shock) for its resolution within the first 72 hours in premature infants under 1,500 g. The main questions it aims to answer are: * Does the early use of hydr…
Phase: PHASE4 • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a psoriasis drug heal these stubborn skin ulcers?
Disease control Recruiting nowA single-arm open-label study assessing short-term (week 6, 16) and long-term (week 32) efficacy of guselkumab in adult participants with pyoderma gangrenosum (PG)
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart valve fix may also shield kidneys in seniors
Disease control Recruiting nowThe hypothesis is that renal function will improve following tricuspid valve intervention. A reduction in renal biomarkers is also expected. Furthermore, based on previous assessments, it is anticipated that there will be an improvement in volume status (reduced edema), symptom b…
Sponsor: Robert Bosch Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Bladder bacteria transplant shows promise for painful condition
Disease control CompletedTo clinically validate the pathological role of Cer accumulation and evaluate a novel microbiota-targeted intervention, we conducted a comprehensive analysis of bladder mucosal specimens from a well-characterized patient cohort stratified according to the established histopatholo…
Phase: PHASE1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a common drug mend a broken heart? new trial aims to find out
Disease control Recruiting nowThe goal of this clinical trial is to investigate the impact of repetitive acute Cyclosporine A (CsA) bolus therapy in patients suffering from TTS with an elevated risk of impaired outcome. The main question it aims to answer is whether CsA reduces myocardial injury (primary outc…
Phase: PHASE2 • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study tests cheaper breast cancer screening for High-Risk women
Diagnosis Recruiting nowWomen at high risk of breast cancer (BC) should undergo annual magnetic resonance imaging (MRI) and digital mammography (DM) from at least ages 35 to 60. While MRI is an expensive and scarce resource, contrast-enhanced mammography (CEM) is a less costly and time-consuming alterna…
Phase: NA • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Blood test may end guesswork in Crohn's drug choice
Knowledge-focused Recruiting nowThis is a multicentre, prospective, randomised, controlled, open-label study to assess the efficacy, safety, and cost-effectiveness of epigenome-guided treatment selection compared to usual standard-of-care (SOC) treatment selection in patients initiating biologic therapy for the…
Phase: NA • Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Old sedative, new trick: amobarbital may shield the heart during bypass surgery
Disease control CompletedExplore the effects of amobarbital on myocardial protection and prognosis in patients undergoing cardiac surgery with cardiopulmonary bypass, investigate the new usage of old drugs, and provide reliable clinical scientific basis for its potential value in better clinical treatmen…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Heart-Safe prostate cancer treatment? new trial pits two hormone combos
Disease control Recruiting nowThis phase III/IV trial compares the impact of leuprolide and abiraterone acetate (AA) versus relugolix and AA on the heart in hormone-naive patients with advanced prostate cancer receiving pelvic radiation therapy. Leuprolide is in a class of medications called gonadotropin-rele…
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug aims to slow vision loss in Age-Related blindness
Disease control OngoingThis study is open to adults aged 50 years and older with geographic atrophy that was diagnosed by imaging of the retina. The purpose of this study is to find out whether a medicine called BI 1584862 improves the eyes in people with geographic atrophy and to find the most suitabl…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New injection aims to tackle obesity – early human trial begins
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending doses of WVE-007 when administered subcutaneously (SC) . Part A is a single ascending dose study in adults living with overweight and obesity. The Part B of the stu…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Primary care teams take on substance use: new study tests collaborative model
Disease control OngoingThe purpose of this trial is to test the efficacy of a collaborative care intervention to address opioid- and/or stimulant-involved polysubstance use in adult primary care patients with moderate to severe substance use disorders (SUD). The primary aims are to reduce days of opioi…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Bone-Anchored prosthesis could replace painful sockets for amputees
Disease control Recruiting nowLimb amputation is a traumatic event that significantly reduces the ability to perform daily activities, impairs mobility, and lowers quality of life. In Italy, approximately 4 million people live with disabilities, with 1.2 million having motor disabilities. Among lower limb amp…
Phase: NA • Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New Vaccine-Drug combo takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis research is being done to determine if the combination of the Dendritic Cell (DC)/ Multiple Myeloma (MM) fusion vaccine with elranatamab is safe and effective in treating Relapsed or Refractory Multiple Myeloma (MM). The names of the study drugs and vaccine involved in this…
Phase: PHASE1 • Sponsor: David Avigan • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Tiny tailbone device may calm urgent bathroom trips for colitis patients
Symptom relief Recruiting nowUlcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a …
Phase: NA • Sponsor: Boomerang Medical • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New eczema shot shows promise in Mid-Stage trial
Symptom relief CompletedThis is a parallel, Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of lunsekimig monotherapy in adult participants (aged 18 to 80 years, inclusive) with moderate-to-severe atopic dermatitis (AD). This st…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can radiofrequency and exercise ease pelvic pain in breast cancer survivors?
Symptom relief Recruiting nowBreast cancer has a high impact, affecting 2.3 million women worldwide in 2022. In Spain, there were 40,203 new cases in 2023. In addition to the economic and social costs, patients suffer genitourinary dysfunctions due to cancer treatments. Genitourinary Menopausal Syndrome (GUS…
Phase: NA • Sponsor: SERGIO MONTERO NAVARRO • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New drug duo targets tough blood cancers in early trial
Disease control Recruiting nowA non-randomized phase Ib study of PC14586 (PMV therapeutics) in patients diagnosed with TP53Y220C-mutant myeloid malignancies, including AML and MDS.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Precision radiation combo aims to tame High-Risk prostate cancer
Disease control OngoingThis study is trying to find out if the combination of Androgen deprivation therapy (ADT), MRI guided high dose radiation (HDR) brachytherapy treatment (internal radiation implant procedure) and external beam radiation therapy (EBRT) treatments lead to less side effects. This stu…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC